Read More
Paul Chan to lead Nanjing delegation to foster innovation ties
11-10-2026 21:38 HKT
'Human' named Cambridge Dictionary's Word of the Year
19-11-2026 03:01 HKT




Guangzhou Baiyunshan Pharmaceutical (0874) said its fund has agreed to buy an 11 percent stake in Nanjing Pharmaceutical for 749 million yuan (HK$816.9 million).
GP Fund II will become the second-largest shareholder of the target company following the transaction, according to a filing on Sunday.
Nanjing Pharmaceutical is a pharmaceutical distribution company, engaged primarily in pharmaceutical wholesale, retail, "Internet Plus", and third-party logistics.
Its market network covers Jiangsu, Anhui, Hubei, Fujian, and Kunming City in the southwestern region, possessing extensive operational experience, resources, and brand recognition in regional markets, the filing said.
Download The Standard app to stay informed with news, updates, and significant events: